Bandingkan Harga & Kinerja Arsy Buana Travelindo Tbk. (HAJJ) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Arsy Buana Travelindo Tbk. dan Organon Pharma Indonesia Tbk.: Arsy Buana Travelindo Tbk. diperdagangkan di Rp112 (kapitalisasi pasar 276,48 M, volume 24 jam 4,8 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Arsy Buana Travelindo Tbk. jauh lebih besar — sekitar 2,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HAJJ | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 276,48 M | 104,4 M |
Volume | 4,8 jt | — |
Lot | 48,03 rb | — |
Perputaran | 535,28 jt | — |
Harga Rata-rata | 111,44 | — |
Nilai Transaksi | 535,28 jt | — |
Harga Ekuilibrium Indikatif | 112 | — |
Volume Ekuilibrium Indikatif | 3 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Arsy Buana Travelindo Tbk.
PT Arsy Buana Travelindo Tbk (the Entity) was established based on Notarial Deed No. 25 dated November 21, 2016 of Harra Mieltuani Lubis SH. The Entity started its commercial operations in 2018. PT Madinah Iman Wisata is the parent entity, whereas Entin Suryatin is the ultimate beneficial owner.
Selengkapnya di halaman HAJJ →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
